Drug testing programs are a common component of workplace safety strategies. When implemented thoughtfully, they can help organizations address a range of workplace needs, including compliance obligations, post-incident response, fitness-for-duty considerations and potential safety risks related to impairment, while also supporting workers’ health and wellbeing.
Testing may be used in many workplace situations, such as meeting regulatory requirements, responding to reasonable suspicion or post-incident events, informing return-to-work decisions or reinforcing workplace policies in safety-sensitive environments. Testing also can intersect with a wide range of substance use situations, including lawful off-duty use, prescribed medications, occasional or past use and when a positive result does not indicate current impairment.
Because of this, it is important not to assume that every positive test result reflects a substance use disorder (SUD). SUDs are treatable health conditions, and many people recover successfully with the right support. Workplaces can play an important role in promoting both safety and wellbeing by recognizing potential impairment risks while also offering prevention resources, early support, and recovery-supportive policies that help employees access care.
Drug testing is most effective when integrated into a broader workplace wellbeing strategy that prioritizes safety, prevention, treatment and recovery support.
● One recent employer survey reported that 40% of employers conduct drug testing for both regulated and nonregulated roles
● Another study found that 50.6% of employed U.S. adults reported a workplace drug testing policy, with greater exposure concentrated in safety-sensitive settings such as transportation and the public sector
● Quest Diagnostics 2025 Drug Testing Index shows that substance use remains a real workplace issue, but positivity rates vary widely depending on why the test is being conducted; the Index showed a 4.4% overall drug positivity rate in the combined U.S. workforce in 2024
● Positivity was much higher in tests tied to concern or events, including 33.1% for for-cause testing and 10.2% for post-accident testing in the U.S. workforce
Workplace drug testing typically involves biological testing methods, such as urine, saliva, hair or blood tests, to detect the presence of specific substances in the body. Detection windows can vary widely depending on the testing method, the substance being tested, patterns of use and individual factors, meaning some tests are better suited to identifying recent use while others may detect substance presence for a longer period.
Organizations may use drug testing programs for several purposes:
● Promoting workplace safety, particularly in safety-sensitive roles
● Deterring substance misuse in the workplace
● Supporting compliance with federal or industry regulations
● Identifying workers who may benefit from treatment or recovery support
Drug testing alone does not measure real-time impairment. Instead, it detects the presence of substances or their metabolites, which may remain in the body after the effects have worn off. As a result, many organizations combine testing programs with broader safety strategies such as supervisor impairment recognition training, impairment recognition training, occupational assessment and employee assistance programs.
Pre-employment testing
Conducted before hiring to determine whether a job candidate has recently used specific substances.
Random testing
Employees are selected randomly for testing during employment. Random testing is common in highly regulated industries such as transportation.
Reasonable cause testing
Testing conducted when a trained supervisor observes signs of potential impairment, such as behavioral changes or safety concerns.
Post-incident testing
Testing performed after a workplace incident or near-miss to determine whether substance use may have contributed.
Return-to-duty or follow-up testing
Used when an employee returns to work after a violation or treatment program to ensure compliance with workplace policies.
Drug testing panels vary depending on the workplace, industry and purpose of testing. A panel is the group of substances included in a test. The most common is the 5-panel test, which typically screens for cannabis metabolites, cocaine metabolites, amphetamines, opiates and PCP. Expanded panels, such as 7-panel, 9-panel, 10-panel or 12-panel tests, may also test for substances such as benzodiazepines, barbiturates, methadone, and oxycodone.
No drug test panel detects every substance. Drugs and drug formulations continue to change, and some substances will only be identified if they are specifically included in the panel. Standard tests may not detect newer synthetic drugs, some prescription medications, or alcohol without separate testing. Because of this, it is important for employers to understand the limits of the panel they use and not assume that any single test provides a complete picture of substance-related risk or current impairment.
Drug testing policies must comply with federal, state and local regulations, which can vary significantly. For example:
● Workers in certain safety-sensitive roles are subject to mandatory testing under federal regulations such as U.S. Department of Transportation (DOT) rules
● State laws may influence testing procedures, employee protections and cannabis-related policies
● Organizations must also consider privacy protections, nondiscrimination laws and disability accommodation requirements
Regulatory requirements are complex and evolving. Consult legal counsel or qualified professionals when developing or updating drug testing policies.
Impairment related to alcohol, drugs or medication can increase the risk of workplace incidents, especially in jobs involving vehicles, heavy equipment or hazardous environments. SUDs affect a significant portion of the workforce, many in safety-sensitive industries. Addressing substance misuse through workplace policies, prevention and treatment access can improve safety outcomes and reduce costs associated with absenteeism and turnover. However, drug testing programs are only one tool. Evidence suggests comprehensive approaches that include prevention, education and recovery support are more effective than testing alone.
Effective drug testing programs balance workplace safety, employee wellbeing and legal compliance. Consider these best practices:
NSC Substance Use Cost Calculator – Methodology Report and Brief
Companion report and summary brief explaining data sources, assumptions and methodology used to estimate the costs of substance use to employers.
NSC Supervisor Training on Impairment Recognition
Supervisor training to recognize signs of impairment, respond to workplace concerns and understand their role in organizational policies and procedures.
Frequently Asked Questions About Federal Workplace Drug Testing
SAMHSA FAQ on federal workplace drug-testing requirements, including the Mandatory Guidelines, authorized specimen types, laboratory and collection standards, medical review officer review and common questions about marijuana, CBD, opioids and employee rights under federal testing programs.
Drug-Safe Workplace Webinar Series
A series of webinars, podcasts and resources focused on building safer workplaces through substance use prevention, testing considerations and recovery-supportive practices.
Quest Diagnostics 2025 Drug Testing Index™ Report
Annual analysis of millions of workplace drug tests that provides insights into national drug positivity trends and emerging patterns affecting employers.
SAMHSA Workplace Drug Testing Resources
Federal guidance and tools to help employers understand workplace drug testing policies, regulatory requirements and best practices for implementing testing programs.
Evolution of Workplace Drug Testing: What Employers Need to Know for 2026
Overview of emerging trends and legal considerations shaping workplace drug testing in 2026, including evolving federal and state policies, compliance challenges and practical considerations for employers.
DOT’s Notice on Testing for Marijuana
U.S. Department of Transportation notice clarifying that state or recreational marijuana laws do not change DOT drug testing requirements for safety-sensitive transportation employees.
There are no items in your cart